Annual Total Long Term Liabilities
$1.56 B
-$255.00 M-14.07%
31 December 2023
Summary:
Moderna annual total long term liabilities is currently $1.56 billion, with the most recent change of -$255.00 million (-14.07%) on 31 December 2023. During the last 3 years, it has risen by +$1.17 billion (+302.33%). MRNA annual total long term liabilities is now -14.07% below its all-time high of $1.81 billion, reached on 31 December 2022.MRNA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$1.68 B
+$70.00 M+4.36%
30 September 2024
Summary:
Moderna quarterly total long term liabilities is currently $1.68 billion, with the most recent change of +$70.00 million (+4.36%) on 30 September 2024. Over the past year, it has increased by +$65.00 million (+4.04%). MRNA quarterly long term liabilities is now -7.56% below its all-time high of $1.81 billion, reached on 31 December 2022.MRNA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNA Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -14.1% | +4.0% |
3 y3 years | +302.3% | +98.9% |
5 y5 years | +644.6% | +775.8% |
MRNA Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -14.1% | +302.3% | -7.6% | +98.9% |
5 y | 5 years | -14.1% | +644.6% | -7.6% | +775.8% |
alltime | all time | -14.1% | >+9999.0% | -7.6% | >+9999.0% |
Moderna Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $1.68 B(+4.4%) |
June 2024 | - | $1.60 B(+4.8%) |
Mar 2024 | - | $1.53 B(-1.6%) |
Dec 2023 | $1.56 B(-14.1%) | $1.56 B(-3.3%) |
Sept 2023 | - | $1.61 B(-11.1%) |
June 2023 | - | $1.81 B(+2.8%) |
Mar 2023 | - | $1.76 B(-2.7%) |
Dec 2022 | $1.81 B(+29.8%) | $1.81 B(+44.2%) |
Sept 2022 | - | $1.26 B(+0.9%) |
June 2022 | - | $1.25 B(-3.9%) |
Mar 2022 | - | $1.30 B(-7.2%) |
Dec 2021 | $1.40 B(+260.7%) | $1.40 B(+65.8%) |
Sept 2021 | - | $842.00 M(+38.3%) |
June 2021 | - | $609.00 M(+46.7%) |
Mar 2021 | - | $415.00 M(+7.2%) |
Dec 2020 | $387.00 M(+42.5%) | $387.00 M(-7.3%) |
Sept 2020 | - | $417.51 M(+10.6%) |
June 2020 | - | $377.47 M(+29.2%) |
Mar 2020 | - | $292.08 M(+7.6%) |
Dec 2019 | $271.50 M(+29.8%) | $271.50 M(+42.0%) |
Sept 2019 | - | $191.25 M(+3.5%) |
June 2019 | - | $184.74 M(-8.1%) |
Mar 2019 | - | $201.01 M(-3.9%) |
Dec 2018 | $209.10 M(-21.9%) | $209.10 M(-7.6%) |
Sept 2018 | - | $226.31 M(-15.5%) |
Dec 2017 | $267.73 M(-35.1%) | $267.73 M(>+9900.0%) |
Sept 2017 | - | $0.00(0.0%) |
June 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) |
Dec 2016 | $412.51 M(+8325.4%) | - |
Dec 2016 | - | $0.00(-100.0%) |
Sept 2016 | - | $2.47 M(-16.7%) |
June 2016 | - | $2.96 M(+4.3%) |
Mar 2016 | - | $2.84 M(-41.9%) |
Dec 2015 | $4.90 M(-58.0%) | $4.90 M(-18.8%) |
Sept 2015 | - | $6.03 M(-23.9%) |
June 2015 | - | $7.93 M(-19.4%) |
Mar 2015 | - | $9.84 M(-15.5%) |
Dec 2014 | $11.64 M(+35.6%) | $11.64 M(-34.8%) |
Sept 2014 | - | $17.86 M(+44.0%) |
June 2014 | - | $12.41 M(-26.8%) |
Mar 2014 | - | $16.95 M(+97.3%) |
Dec 2013 | $8.59 M(+15.2%) | $8.59 M(+31.8%) |
Sept 2013 | - | $6.51 M(+18.9%) |
June 2013 | - | $5.48 M(-3.7%) |
Mar 2013 | - | $5.69 M(-23.7%) |
Dec 2012 | $7.45 M(+5.4%) | $7.45 M(+54.6%) |
Sept 2012 | - | $4.82 M(-14.4%) |
June 2012 | - | $5.63 M(-33.0%) |
Mar 2012 | - | $8.41 M(+18.9%) |
Dec 2011 | $7.07 M(+17.9%) | $7.07 M(-11.3%) |
Sept 2011 | - | $7.98 M(-11.1%) |
June 2011 | - | $8.98 M(+154.7%) |
Mar 2011 | - | $3.52 M(-41.3%) |
Dec 2010 | $6.00 M | $6.00 M(-33.2%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2010 | - | $8.98 M(-21.9%) |
June 2010 | - | $11.51 M(-10.2%) |
Mar 2010 | - | $12.81 M(+42.6%) |
Dec 2009 | $8.98 M(+132.1%) | $8.98 M(-30.7%) |
Sept 2009 | - | $12.97 M(-1.7%) |
June 2009 | - | $13.19 M(+213.4%) |
Mar 2009 | - | $4.21 M(+8.7%) |
Dec 2008 | $3.87 M(-56.1%) | $3.87 M(-22.9%) |
Sept 2008 | - | $5.03 M(-16.7%) |
June 2008 | - | $6.03 M(-20.5%) |
Mar 2008 | - | $7.58 M(-14.1%) |
Dec 2007 | $8.83 M(-44.0%) | $8.83 M(-35.5%) |
Sept 2007 | - | $13.69 M(-7.5%) |
June 2007 | - | $14.79 M(-2.4%) |
Mar 2007 | - | $15.16 M(-3.9%) |
Dec 2006 | $15.77 M(+92.1%) | $15.77 M(+29.3%) |
Sept 2006 | - | $12.19 M(+12.5%) |
June 2006 | - | $10.84 M(+2.0%) |
Mar 2006 | - | $10.63 M(+29.5%) |
Dec 2005 | $8.21 M(+41.9%) | $8.21 M(+29.5%) |
Sept 2005 | - | $6.34 M(+9.8%) |
June 2005 | - | $5.77 M(+4.4%) |
Mar 2005 | - | $5.53 M(-4.4%) |
Dec 2004 | $5.78 M(+167.3%) | $5.78 M(-5.2%) |
Sept 2004 | - | $6.10 M(+158.3%) |
June 2004 | - | $2.36 M(+12.4%) |
Mar 2004 | - | $2.10 M(-2.9%) |
Dec 2003 | $2.16 M(-70.5%) | $2.16 M(+32.1%) |
Sept 2003 | - | $1.64 M(+8.8%) |
June 2003 | - | $1.50 M(-87.0%) |
Mar 2003 | - | $11.55 M(+57.3%) |
Dec 2002 | $7.34 M(>+9900.0%) | $7.34 M(+16.3%) |
Sept 2002 | - | $6.31 M(+106.7%) |
June 2002 | - | $3.06 M(+76.0%) |
Mar 2002 | - | $1.74 M(+5686.7%) |
Dec 2001 | $30.00 K(-3100.0%) | $30.00 K(-3100.0%) |
Dec 1999 | -$1000.00(-101.0%) | -$1000.00(-101.0%) |
Sept 1999 | - | $100.00 K(-200.0%) |
June 1998 | - | -$100.00 K(-200.0%) |
Dec 1997 | $100.00 K(0.0%) | $100.00 K(0.0%) |
Sept 1997 | - | $100.00 K(0.0%) |
June 1997 | - | $100.00 K(-200.0%) |
Sept 1996 | - | -$100.00 K(-200.0%) |
June 1996 | $100.00 K(0.0%) | $100.00 K(-50.0%) |
Mar 1996 | - | $200.00 K(0.0%) |
Dec 1995 | - | $200.00 K(0.0%) |
Sept 1995 | - | $200.00 K(+100.0%) |
June 1995 | $100.00 K(-80.0%) | $100.00 K(-66.7%) |
Mar 1995 | - | $300.00 K(0.0%) |
Dec 1994 | - | $300.00 K(0.0%) |
Sept 1994 | - | $300.00 K(-40.0%) |
June 1994 | $500.00 K | $500.00 K(0.0%) |
Mar 1994 | - | $500.00 K(0.0%) |
Dec 1993 | - | $500.00 K(-16.7%) |
Sept 1993 | - | $600.00 K |
FAQ
- What is Moderna annual total long term liabilities?
- What is the all time high annual total long term liabilities for Moderna?
- What is Moderna annual total long term liabilities year-on-year change?
- What is Moderna quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Moderna?
- What is Moderna quarterly long term liabilities year-on-year change?
What is Moderna annual total long term liabilities?
The current annual total long term liabilities of MRNA is $1.56 B
What is the all time high annual total long term liabilities for Moderna?
Moderna all-time high annual total long term liabilities is $1.81 B
What is Moderna annual total long term liabilities year-on-year change?
Over the past year, MRNA annual total long term liabilities has changed by -$255.00 M (-14.07%)
What is Moderna quarterly total long term liabilities?
The current quarterly long term liabilities of MRNA is $1.68 B
What is the all time high quarterly long term liabilities for Moderna?
Moderna all-time high quarterly total long term liabilities is $1.81 B
What is Moderna quarterly long term liabilities year-on-year change?
Over the past year, MRNA quarterly total long term liabilities has changed by +$65.00 M (+4.04%)